A detailed history of Allworth Financial LP transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 750 shares of GTHX stock, worth $5,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
750
Previous 750 -0.0%
Holding current value
$5,362
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$7.6 - $11.02 $3,891 - $5,642
-512 Reduced 40.57%
750 $6,000
Q3 2021

Nov 02, 2021

BUY
$13.16 - $22.47 $16,607 - $28,357
1,262 New
1,262 $17,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.